196 related articles for article (PubMed ID: 31673391)
1. Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI).
Anstensrud AK; Woxholt S; Sharma K; Broch K; Bendz B; Aakhus S; Ueland T; Amundsen BH; Damås JK; Hopp E; Kleveland O; Stensæth KH; Opdahl A; Kløw NE; Seljeflot I; Andersen GØ; Wiseth R; Aukrust P; Gullestad L
Open Heart; 2019; 6(2):e001108. PubMed ID: 31673391
[TBL] [Abstract][Full Text] [Related]
2. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
Broch K; Anstensrud AK; Woxholt S; Sharma K; Tøllefsen IM; Bendz B; Aakhus S; Ueland T; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Bendz C; Hopp E; Kleveland O; Stensæth KH; Opdahl A; Kløw NE; Seljeflot I; Andersen GØ; Wiseth R; Aukrust P; Gullestad L
J Am Coll Cardiol; 2021 Apr; 77(15):1845-1855. PubMed ID: 33858620
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial.
Huse C; Anstensrud AK; Michelsen AE; Ueland T; Broch K; Woxholt S; Yang K; Sharma K; Tøllefsen IM; Bendz B; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Quiles-Jiménez A; Bjerkeli V; Bendz C; Kleveland O; Stensaeth KH; Opdahl A; Kløw NE; Andersen GØ; Wiseth R; Halvorsen B; Gullestad L; Seljeflot I; Aukrust P; Osnes L; Dahl TB
EBioMedicine; 2022 Jun; 80():104013. PubMed ID: 35504178
[TBL] [Abstract][Full Text] [Related]
4. Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab.
Woxholt S; Ueland T; Aukrust P; Anstensrud AK; Broch K; Tøllefsen IM; Ryan L; Bendz B; Hopp E; Kløw NE; Seljeflot I; Halvorsen B; Dahl TB; Huse C; Andersen GØ; Gullestad L; Wiseth R; Amundsen BH; Damas JK; Kleveland O
Open Heart; 2023 Aug; 10(2):. PubMed ID: 37591633
[TBL] [Abstract][Full Text] [Related]
5. Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI).
Madsen JM; Obling LER; Rytoft L; Folke F; Hassager C; Andersen LB; Vejlstrup N; Bang LE; Engstrøm T; Lønborg JT
Trials; 2023 Dec; 24(1):808. PubMed ID: 38102687
[TBL] [Abstract][Full Text] [Related]
6. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.
Kleveland O; Kunszt G; Bratlie M; Ueland T; Broch K; Holte E; Michelsen AE; Bendz B; Amundsen BH; Espevik T; Aakhus S; Damås JK; Aukrust P; Wiseth R; Gullestad L
Eur Heart J; 2016 Aug; 37(30):2406-13. PubMed ID: 27161611
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
[TBL] [Abstract][Full Text] [Related]
8. Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI).
Siddiqi N; Bruce M; Neil CJ; Jagpal B; Maclennon G; Cotton SC; Papadopoulo SA; Bunce N; Lim P; Schwarz K; Singh S; Hildick-Smith D; Horowitz JD; Madhani M; Boon N; Kaski JC; Dawson D; Frenneaux MP
J Transl Med; 2013 May; 11():116. PubMed ID: 23648219
[TBL] [Abstract][Full Text] [Related]
9. Platelet inhibition to target reperfusion injury trial: Rationale and study design.
Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ
Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.
Bulluck H; Fröhlich GM; Mohdnazri S; Gamma RA; Davies JR; Clesham GJ; Sayer JW; Aggarwal RK; Tang KH; Kelly PA; Jagathesan R; Kabir A; Robinson NM; Sirker A; Mathur A; Blackman DJ; Ariti C; Krishnamurthy A; White SK; Meier P; Moon JC; Greenwood JP; Hausenloy DJ
Clin Cardiol; 2015 May; 38(5):259-66. PubMed ID: 25990305
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.
Bulluck H; Fröhlich GM; Nicholas JM; Mohdnazri S; Gamma R; Davies J; Sirker A; Mathur A; Blackman D; Garg P; Moon JC; Greenwood JP; Hausenloy DJ
Am Heart J; 2019 May; 211():60-67. PubMed ID: 30893577
[TBL] [Abstract][Full Text] [Related]
12. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Ørn S; Ueland T; Manhenke C; Sandanger Ø; Godang K; Yndestad A; Mollnes TE; Dickstein K; Aukrust P
J Intern Med; 2012 Sep; 272(3):267-76. PubMed ID: 22243053
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial.
Jones DA; Andiapen M; Van-Eijl TJ; Webb AJ; Antoniou S; Schilling RJ; Ahluwalia A; Mathur A
BMJ Open; 2013; 3(4):. PubMed ID: 23550096
[TBL] [Abstract][Full Text] [Related]
14. Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.
Nepper-Christensen L; Lønborg J; Høfsten DE; Ahtarovski KA; Bang LE; Helqvist S; Kyhl K; Køber L; Kelbæk H; Vejlstrup N; Holmvang L; Engstrøm T
Circ Cardiovasc Interv; 2018 Sep; 11(9):e006842. PubMed ID: 30354595
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
16. Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial.
Tuñón J; González-Hernández I; Llanos-Jiménez L; Alonso-Martín J; Escudier-Villa JM; Tarín N; Cristóbal C; Sanz P; Pello AM; Aceña Á; Carda R; Orejas M; Tomás M; Beltrán P; Calero Rueda M; Marcos E; Serrano-Antolín JM; Gutiérrez-Landaluce C; Jiménez R; Cabezudo J; Curcio A; Peces-Barba G; González-Parra E; Muñoz-Siscart R; González-Casaus ML; Lorenzo A; Huelmos A; Goicolea J; Ibáñez B; Hernández G; Alonso-Pulpón LM; Farré J; Lorenzo Ó; Mahíllo-Fernández I; Egido J
BMJ Open; 2016 Aug; 6(8):e011287. PubMed ID: 27496232
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
Lincoff AM; Roe M; Aylward P; Galla J; Rynkiewicz A; Guetta V; Zelizko M; Kleiman N; White H; McErlean E; Erlinge D; Laine M; Dos Santos Ferreira JM; Goodman S; Mehta S; Atar D; Suryapranata H; Jensen SE; Forster T; Fernandez-Ortiz A; Schoors D; Radke P; Belli G; Brennan D; Bell G; Krucoff M;
Eur Heart J; 2014 Oct; 35(37):2516-23. PubMed ID: 24796339
[TBL] [Abstract][Full Text] [Related]
18. Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset.
Stiermaier T; Eitel I; de Waha S; Pöss J; Fuernau G; Thiele H; Desch S
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1571-1579. PubMed ID: 28439734
[TBL] [Abstract][Full Text] [Related]
19. Remote ischemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI): study protocol for a randomized controlled trial.
Gaspar A; Pereira MÁ; Azevedo P; Lourenço A; Marques J; Leite-Moreira A
Trials; 2015 Sep; 16():398. PubMed ID: 26350480
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
